anti-OX40L antibody product blog
Tags: Antibody; Monoclonal Antibody; OX40L; anti-OX40L antibody;
The OX40L n/a (Catalog #MBS6120625) is an Antibody produced from Human and is intended for research purposes only. The product is available for immediate purchase. The Human Anti-OX40L (CD252, CD134L, OX40 Ligand, TNFSF4, Tumor Necrosis Factor Superfamily Member 4, TAX Transcriptionally-activated Glycoprotein 1, TXGP1, gp34) reacts with Human and may cross-react with other species as described in the data sheet. MyBioSource\'s OX40L can be used in a range of immunoassay formats including, but not limited to, Flow Cytometry (FC/FACS).Flow Cytometry: 1ug/ml Blocking: Binds to the co-stimulatory human OX40L inhibiting its interaction with OX40 in vitro and in vivo. Optimal dilutions to be determined by the researcher. Researchers should empirically determine the suitability of the OX40L n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
OX40L [CD252; CD134L] is a membrane-expressed cytokine that belongs to the TNF ligand family. It acts as costimulator through interaction with its ligand OX40 on T cells, stimulating T cell activation, proliferation and cytokine production. OX40L is expressed on antigen presenting cells including B cells, dendritic cells, mast cells and endothelium.
Endotoxin: <0.001EU/ug
Immunogen: Recombinant protein corresponding to human OX40L expressed in CHO cells. Note: Preservative Free. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing OX40L are readily searchable from our website. Different antibodies against the same target such as OX40L may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.